CL-2022-000676 - [2025] EWHC 2486 (Comm)
Commercial Court

CL-2022-000676 - [2025] EWHC 2486 (Comm)

Fecha: 01-Oct-2025

The Recommendation

The Recommendation

48.

On 13 March 2020 the European Commission issued a Recommendation (EU) 2020/403 (the “Recommendation”), on which Medpro relies heavily. This provided as follows:

a.

Recital (2) “Bearing in mind that the health and safety of the EU citizens is of upmost priority, it is of paramount importance to ensure that the most appropriate PPE and medical devices ensuring adequate protection are swiftly made available to those who need it most”;

b.

Recital (14) “In accordance with Article 11 of Directive 93/42/EEC … in order to place medical devices on the market, manufacturers shall carry out the applicable conformity assessment procedures and, where compliance with the applicable essential requirements or general safety and performance requirements has been demonstrated by the appropriate procedure, affix the CE marking. Derogations from conformity assessment procedures may be authorised by Member States, on duly justified request, for the placing on the market and putting into service, within the territory of the Member State concerned, of individual devices the use of which is in the interest of protection of health.

c.

Recommendation [8] “PPE or medical devices not bearing the CE marking could also be assessed and part of a purchase organised by the relevant Member State authorities provided that is ensured that such products are only available for the healthcare workers for the duration of the current health crisis and that they are not entering the regular distribution channels and made available to other users.”

49.

As DHSC noted, the Recommendation had no legal force. It did however evidence an atmosphere in which governmental departments were open to measured departures from the precise regulatory requirements.